Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is taken once a week, not every day. Each injection delivers a week's worth of semaglutide, and that weekly rhythm is built into how the medicine works — the drug's half-life keeps it active in your body across all seven days. Missing that frequency, or changing it without clinical guidance, can affect both tolerability and results. Wegovy is a prescription-only medicine; a prescriber assesses whether it is suitable for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you start Wegovy, one of the first practical decisions is which day of the week suits you best. Monday morning before breakfast, Thursday evening after dinner, it genuinely does not matter, provided you keep returning to the same day each week. Semaglutide has a half-life of roughly seven days, which is precisely why the dosing interval is weekly rather than daily: the drug remains active throughout the full seven-day window between injections, steadily suppressing appetite and slowing gastric emptying.
Consistency matters more than the specific day. If you habitually inject on a Wednesday and suddenly shift to a Saturday, you create a longer gap that can affect drug levels and, in some people, tolerability. The NHS semaglutide medicines page explains the weekly schedule and what to do if a dose is delayed, that guidance always takes precedence over any general information you read online, including here.
Pick a day that fits your life. Some people tie it to a weekly routine so it becomes automatic, the same way a Saturday shop or a Monday school run becomes second nature.
Wegovy does not begin at its full therapeutic dose. The licensed schedule starts at 0.25 mg weekly for four weeks, then moves through 0.5 mg, 1.0 mg, and 1.7 mg before reaching the 2.4 mg maintenance dose, each step lasting around a month. This graduated approach exists specifically to reduce gastrointestinal side effects: nausea, indigestion, and loose stools are most common when the dose is first introduced or increased, and giving the body time to adapt at each level makes the medicine considerably more tolerable for most people.
The MHRA also approved a single-dose 7.2 mg pen in April 2026 for adults with obesity, representing the highest maintenance level available. Reaching it follows the same step-by-step titration; nobody moves directly to 7.2 mg. Your prescriber decides when and whether a dose increase is appropriate, that review happens before every step, not automatically.
If you are wondering what the cost of treatment looks like across these different dose stages, the Wegovy pricing page sets out the context honestly.
Life is rarely perfectly regular, and questions about flexibility in the dosing window are ones our prescribers hear regularly. NHS guidance on semaglutide specifies what to do if a dose is missed, there is a window within which the missed injection can still be taken, after which it should be skipped and the next dose taken on the usual day. The exact window is stated in the Patient Information Leaflet that comes with your pen; that is the authoritative source, not a search result.
Some people also ask whether injecting slightly early or late by a day or two makes a meaningful difference. The answer depends on how far outside the interval you go, and your prescriber is the right person to advise on your specific situation. Pages covering related timing questions (such as taking Wegovy every six days or stretching to every two weeks) explore what the evidence and guidance say about those variations.
Keeping to the weekly rhythm matters beyond just maintaining drug levels. Clinical trials underpinning Wegovy's licence, including the STEP 1 study published in the New England Journal of Medicine, enrolled participants on a structured weekly schedule alongside lifestyle changes, recording an average weight reduction of around 15% over 68 weeks at the 2.4 mg dose. The schedule in those trials was consistent; real-world adherence tends to reflect trial conditions when the routine is solid.
Alongside timing, the injection technique itself (rotating between the abdomen, thigh, and upper arm, using a clean site each time) plays a role in tolerability. The practical Wegovy tips page covers that kind of day-to-day detail. For a broader view of how semaglutide works as a treatment, the semaglutide overview is a good starting point, and the Wegovy treatment page explains what is included when you access it through a regulated UK pharmacy.
If you are still deciding whether weight-loss treatment is right for you, the weight-loss treatments overview compares the options available. When you are ready to take the next step, you can check your eligibility with our prescribers, a real clinician reviews every consultation the same day, at no charge.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.